U.S. markets closed

Cardinal Health, Inc. (CAH)

NYSE - NYSE Delayed Price. Currency in USD
74.60+2.13 (+2.94%)
At close: 04:00PM EDT
72.46 -2.14 (-2.87%)
After hours: 07:43PM EDT
  • Dividend

    CAH announced a cash dividend of 0.496 with an ex-date of Mar. 31, 2023

Cardinal Health, Inc.

7000 Cardinal Place
Dublin, OH 43017
United States
614 757 5000

IndustryMedical Distribution
Full Time Employees45,570

Key Executives

NameTitlePayExercisedYear Born
Mr. Jason M. HollarCEO & Director1.12MN/A1973
Ms. Jessica L. MayerChief Legal & Compliance Officer873.45kN/A1970
Mr. Stephen M. MasonChief Exec. Officer of Medical Segment848.88kN/A1972
Mr. Aaron E. AltChief Financial OfficerN/AN/A1973
Ms. Mary C. SchererSr. VP & Chief Accounting OfficerN/AN/AN/A
Ms. Michelle GreeneExec. VP & Chief Information OfficerN/AN/AN/A
Mr. Kevin MoranVP of Investor RelationsN/AN/AN/A
Ms. Ola M. SnowChief HR OfficerN/AN/A1968
Mr. Craig CowmanExec. VP of Strategic Sourcing & Manufacturer ServicesN/AN/AN/A
Ms. Deborah L. WeitzmanChief Exec. Officer of Pharmaceutical DistributionN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Corporate Governance

Cardinal Health, Inc.’s ISS Governance QualityScore as of March 1, 2023 is 1. The pillar scores are Audit: 3; Board: 1; Shareholder Rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.